These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3107906)

  • 1. Inhibition of aldose reductase from human retina.
    Poulsom R
    Curr Eye Res; 1987 Mar; 6(3):427-32. PubMed ID: 3107906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
    Poulsom R
    Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hexonate dehydrogenase and aldose reductase from bovine retina by sorbinil, statil, M79175 and valproate.
    Poulsom R
    Biochem Pharmacol; 1986 Sep; 35(17):2955-9. PubMed ID: 3091036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.
    O'Brien MM; Schofield PJ; Edwards MR
    J Neurochem; 1982 Sep; 39(3):810-4. PubMed ID: 6808090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductases from human retina and bovine lens: dependence of inhibition upon the choice of enzyme substrate.
    Poulsom R
    Prog Clin Biol Res; 1987; 232():341-52. PubMed ID: 3112787
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK; Petrash JM; Sadana IJ; Ansari NH; Partridge CA
    Curr Eye Res; 1982-1983; 2(6):407-10. PubMed ID: 6820339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
    Ares JJ; Kador PF; Miller DD
    J Med Chem; 1986 Nov; 29(11):2384-9. PubMed ID: 3097318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of aldose reductase from human tissues.
    Das B; Srivastava SK
    Diabetes; 1985 Nov; 34(11):1145-51. PubMed ID: 3930326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of aldose reductase inhibitors by determination of IC50 with bovine and rat lens extracts.
    Müller P; Hockwin O; Ohrloff C
    Ophthalmic Res; 1985; 17(2):115-9. PubMed ID: 3920598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal permeability of aldose reductase inhibitor, M79175. I. In vitro study using corneal permeability apparatus.
    Kato A; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):279-86. PubMed ID: 3139808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms.
    Vander Jagt DL; Hunsaker LA; Robinson B; Stangebye LA; Deck LM
    J Biol Chem; 1990 Jul; 265(19):10912-8. PubMed ID: 2113526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, absolute configuration, and conformation of the aldose reductase inhibitor sorbinil.
    Sarges R; Bordner J; Dominy BW; Peterson MJ; Whipple EB
    J Med Chem; 1985 Nov; 28(11):1716-20. PubMed ID: 3934383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P
    Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction.
    Bhatnagar A; Liu S; Das B; Srivastava SK
    Mol Pharmacol; 1989 Dec; 36(6):825-30. PubMed ID: 2513474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.